Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD52 | P43351 | 3/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.64 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.64 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.64 |
| ▸ | ACHE | P22303 | 4/20 | 0.63 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.63 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.63 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.63 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.63 |
| ▸ | ESR1 | P03372 | 1/20 | 0.63 |
| ▸ | PGR | P06401 | 1/20 | 0.63 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | DRD1 | P21728 | 1/20 | 0.63 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | PDE4A | P27815 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanamide SCHEMBL14322562 | 0.92 | RAD52 (0.78) | RAD52HSP90AA1HSPD1HSPE1ACHE | |
| Water SCHEMBL28141136 | 0.89 | RAD52 (0.78) | RAD52HSP90AA1HSPD1HSPE1ACHE | |
| Thiocyanic Acid SCHEMBL6468415 | 0.88 | RAD52 (0.64) | RAD52HSP90AA1HSPD1HSPE1ACHE | |
| SCHEMBL34882 | 0.87 | ACHE (0.81) | RAD52HSP90AA1HSPD1HSPE1ACHE | |
| SCHEMBL15212269 | 0.86 | RAD52 (0.62) | RAD52HSP90AA1HSPD1HSPE1ACHE | |
| Cyanide SCHEMBL28191543 | 0.85 | ACHE (0.71) | RAD52HSP90AA1HSPD1HSPE1ACHE | |
| SCHEMBL30331058 | 0.85 | ACHE (0.71) | RAD52HSP90AA1HSPD1HSPE1ACHE | |
| Bromide SCHEMBL18062500 | 0.84 | ACHE (0.82) | RAD52HSP90AA1HSPD1HSPE1ACHE | |
| Fluoride Ion SCHEMBL1502795 | 0.84 | ACHE (0.77) | RAD52HSP90AA1HSPD1HSPE1ACHE | |
| Bromide SCHEMBL382846 | 0.84 | ACHE (0.82) | RAD52HSP90AA1HSPD1HSPE1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1675211-B1 | ELECTROLYTE COMPOSITION AND PHOTOELECTRIC CONVERTER USING SAME | FUJIKURA LTD (JP) | 2019-04-17 | — | — | EP | claimed |
| US-20080060698-A1 | Electrolyte Composition And Photoelectric Conversion Element Utilizing The Same | FUJIKURA LTD. (JP) | 2008-03-13 | — | — | US | claimed |
| CN-110484746-B | Noble metal leaching agent and method for recovering noble metal from waste catalyst | 浙江工业大学 | 2021-12-07 | — | — | CN | disclosed |
| CN-110607456-B | Method for recovering noble metal in waste carbon-supported noble metal catalyst by using ionic liquid | 浙江工业大学 | 2021-07-27 | — | — | CN | disclosed |
| CN-110607456-A | Method for recovering noble metal in waste carbon-supported noble metal catalyst by using ionic liquid | 浙江工业大学 | 2019-12-24 | — | — | CN | disclosed |
| EP-1675211-B1 | ELECTROLYTE COMPOSITION AND PHOTOELECTRIC CONVERTER USING SAME | FUJIKURA LTD (JP) | 2019-04-17 | — | — | EP | disclosed |
| EP-2872489-B1 | SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2016-12-21 | — | — | EP | disclosed |
| US-9512080-B2 | Synthesis of acridinium compounds by N-alkylation of acridans | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2016-12-06 | — | — | US | disclosed |
| US-20150197491-A1 | SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2015-07-16 | — | — | US | disclosed |
| EP-2872489-A1 | SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS | Siemens Healthcare Diagnostics Inc. (US) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014011762-A1 | SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS | SIEMENS HEAL THCARE DIAGNOSTICS INC. (US) | 2014-01-16 | — | — | WO | disclosed |
| EP-2215063-B1 | FACILE N-ALKYLATION OF ACRIDINE COMPOUNDS IN IONIC LIQUIDS | SIEMENS HEALTHCARE DIAGNOSTICS (US) | 2013-10-30 | — | — | EP | disclosed |
| US-20120330023-A1 | Alkyl Pyridinium Dicyanamides and Method For The Production Thereof | LONZA AG (CH) | 2012-12-27 | — | — | US | disclosed |
| US-8293908-B2 | Facile N-alkylation of acridine compounds in ionic liquids | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2012-10-23 | — | — | US | disclosed |
| US-20100256380-A1 | FACILE N-ALKYLATION OF ACRIDINE COMPOUNDS IN IONIC LIQUIDS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2010-10-07 | — | — | US | disclosed |
| EP-1675211-A1 | ELECTROLYTE COMPOSITION AND PHOTOELECTRIC CONVERTER USING SAME | Fujikura Ltd. (JP) | 2006-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256380-A1 | FACILE N-ALKYLATION OF ACRIDINE COMPOUNDS IN IONIC LIQUIDS | ACR, MGMT, DNMT3A | RAD52 2418/4885HSP90AA1 3824/4885HSPD1 3352/4885 |
| US-20150197491-A1 | SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS | ACR, MCL1, MGMT | RAD52 2479/4885HSP90AA1 2823/4885HSPD1 2437/4885 |
| US-20120330023-A1 | Alkyl Pyridinium Dicyanamides and Method For The Production Thereof | CYB5R3, CBR3, IDH1 | RAD52 820/4885HSP90AA1 3592/4885HSPD1 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.